RADIMMUNE THERAPEUTICS INC has a total of 15 patent applications. Its first patent ever was published in 2018. It filed its patents most often in Canada, China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and biotechnology are KINETA CHRONIC PAIN LLC, AMPHIVENA THERAPEUTICS INC and IDP DISCOVERY PHARMA S L.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 2 | |
#2 | China | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Israel | 2 | |
#5 | Republic of Korea | 2 | |
#6 | United States | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 2 | |
#8 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Rickles David J | 15 |
#2 | Dadachova Ekaterina | 15 |
#3 | Bryan Ruth A | 7 |
Publication | Filing date | Title |
---|---|---|
US2020317766A1 | Antibodies to centrin-1, methods of making, and uses thereof | |
CA3074715A1 | Melanin antibodies and uses thereof |